Investor Relations

Stock price graph

GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.

For investor information, please contact IR@genmarkdx.com.

Annual Reports

2014 Proxy Statement

2013 Annual Report

2013 Proxy Statement

2012 Annual Report

2011 Annual Report

2012 Proxy Statement


Recent Releases

Jul 28, 2014
GenMark Announces Positive Preliminary Second Quarter Results

Jul 17, 2014
GenMark Diagnostics Schedules Second Quarter 2014 Financial Results Conference Call for August 11, 2014

View all releases »

Events

Aug 11, 2014 at 4:30 PM ET
GenMark Diagnostics Second Quarter Earnings

View all events »

Related Links

Stock Quote
Price:
11.02
Change:
+ 0.32
Day High:
11.04
Day Low:
10.65
Volume:
155,200
NASDAQ
GNMK
4:00 PM ET on Aug 1, 2014
Delayed at least 20 minutes.
Provided by eSignal.